CME Group Inc.
Financial ServicesNASDAQ:CME · NASDAQ Global Select
+$7.35 today
Vol 2.77M · Avg 2.65M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
14.1%
avg 10.4%
ROIC
1.6%
avg 4.8%
ROA
2.0%
avg 2.4%
Analysis
ROE is currently the strongest return metric at 14.1% versus its period average of 10.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Terrence A. Duffy | Chairman & Chief Executive Officer | $10.02M | — | 68 | $55,630.00 | 0.02% |
Lynne Fitzpatrick | President & Chief Financial Officer | $2.21M | — | 47 | $26,428.00 | <0.01% |
Derek Sammann | Senior MD & Global Head of Commodities Markets | $1.58M | — | 58 | $16,939.00 | <0.01% |
Julie Winkler | Senior MD & Chief Commercial Officer | $1.57M | — | 51 | $33,768.00 | <0.01% |
Sunil Cutinho | Chief Information Officer | $1.57M | — | 54 | $27,244.00 | <0.01% |
Hilda Harris Piell | Senior MD & Chief Human Resources Officer | — | — | 58 | $27,702.00 | <0.01% |
Anita Liskey | Senior Managing Director of Corporate Marketing & Communications | — | — | 61 | — | — |
Adam Minick | Investor Contact | — | — | — | — | — |
Jack Tobin | MD & Chief Accounting Officer | — | — | 62 | $25,588.00 | <0.01% |
John C. Peschier | Managing Director of Investor Relations | — | — | 58 | $55,238.00 | 0.02% |
Jonathan L. Marcus | Senior MD & General Counsel | — | — | — | $7,192.00 | <0.01% |
Suzanne Sprague | Senior MD, Group Chief Operating Officer & Global Head of Clearing | — | — | — | $16,351.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
8
$655,117.00
Sells
20
$30.38M
Net Sentiment
$29.72M
Net selling
Most Active
SHEPARD WILLIAM R
8 transactions
1–10 of 28
Analysis
Insiders reported 8 buys worth $655,117.00 and 20 sells worth $30.38M over the last 12 months. That adds up to net selling of $29.72M. SHEPARD WILLIAM R was the most active insider with 8 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +11.0% | +10.1% (15yr)1 analysts |
| Revenue | N/A | N/A | +4.5% | +6.6% (15yr)7 analysts |
| Net Income | N/A | N/A | +11.6% | +10.6% (15yr)7 analysts |
| EBIT | N/A | N/A | +5.5% | +9.5% (15yr)7 analysts |
Analysis
Recent growth has been strongest in Net Income at +11.6% over three years. Forward estimates point to Net Income at +10.6% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Mizuho Financial Group, Inc.
NYSE:MFG
$117.92B
Bank of Montreal
NYSE:BMO
$117.88B
The Bank of Nova Scotia
NYSE:BNS
$102.98B
ICICI Bank Limited
NYSE:IBN
$99.64B
Marsh & McLennan Companies, Inc.
MMC
$89.82B
Intercontinental Exchange, Inc.
NYSE:ICE
$79.47B
Moody's Corporation
NYSE:MCO
$78.24B
Brookfield Asset Management Ltd.
NYSE:BAM
$75.26B
Nasdaq, Inc.
NASDAQ:NDAQ
$50.32B
Coinbase Global, Inc.
NASDAQ:COIN
$42.10B
Who manages CME?
CME Group Inc. (CME) lists 12 active executives. The top listed executive is Hilda Harris Piell, Senior MD & Chief Human Resources Officer.
Are CME insiders buying or selling?
Recent insider activity shows net selling of $97,876.89.
Explore More
Continue the stock analysis
Jump to another research area for this company.